Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Receivables - Net: 2019-2020

Historic Receivables - Net for Seres Therapeutics (MCRB) over the last 2 years, with Dec 2020 value amounting to $9.4 million.

  • Seres Therapeutics' Receivables - Net was N/A to $351,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $351,000, marking a year-over-year change of. This contributed to the annual value of $9.4 million for FY2020, which is 425.88% up from last year.
  • Seres Therapeutics' Receivables - Net amounted to $9.4 million in FY2020, which was up 425.88% from $1.8 million recorded in FY2019.
  • Over the past 5 years, Seres Therapeutics' Receivables - Net peaked at $9.4 million during FY2020, and registered a low of $1.8 million during FY2019.
  • In the last 2 years, Seres Therapeutics' Receivables - Net had a median value of $5.6 million in 2019 and averaged $5.6 million.
  • Data for Seres Therapeutics' Receivables - Net shows a peak YoY soared of 425.88% (in 2020) over the last 5 years.
  • Seres Therapeutics' Receivables - Net (Yearly) stood at $1.8 million in 2019, then spiked by 425.88% to $9.4 million in 2020.